Slobodan Antić
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmacology top 5%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 10
- Diabetes Management and Research 4
- Growth Hormone and Insulin-like Growth Factors 4
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
-
- Metabolism, Diabetes, and Cancer 8
- Co-authors
- Bipin Sethi (2 shared papers)David Russell‐Jones (2 shared papers)Rafael Simó (2 shared papers)O. Schmitz (2 shared papers)Nebojša Lalić (3 shared papers)Allan Vaag (2 shared papers)Marija Zdravković (1 shared paper)Vladisav Stefanović (10 shared papers)
- Journals
- Diabetes & Metabolism (2 papers)Renal Failure (2 papers)Annals of Clinical Biochemistry International Journal of Laboratory Medicine (2 papers)Diabetes Technology & Therapeutics (1 paper)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)
- Partner nations
- SerbiaUnited KingdomIndonesia
In The Last Decade
Slobodan Antić
33 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Endocrinology, Diabetes and Metabolism 859
- Pharmacology 201
- Periodontics 46
- Nephrology 59
- Molecular Biology 464
Countries citing papers authored by Slobodan Antić
This map shows the geographic impact of Slobodan Antić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Slobodan Antić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Slobodan Antić more than expected).
Fields of papers citing papers by Slobodan Antić
This network shows the impact of papers produced by Slobodan Antić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Slobodan Antić. The network helps show where Slobodan Antić may publish in the future.
Co-authors
The 25 scholars most cited alongside Slobodan Antić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial Hit paper breakdown → | 2009 | 688 |
| 2 | 2006 | 54 | |
| 3 | 2007 | 42 | |
| 4 | 2012 | 39 | |
| 5 | 2008 | 39 | |
| 6 | 2001 | 34 | |
| 7 | 2012 | 30 | |
| 8 | 2008 | 29 | |
| 9 | 2009 | 24 | |
| 10 | 1999 | 23 | |
| 11 | 2014 | 22 | |
| 12 | 2013 | 20 | |
| 13 | 2008 | 18 | |
| 14 | Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus. | 2004 | 14 |
| 15 | 2007 | 7 | |
| 16 | 2007 | 7 | |
| 17 | [Exercise as a therapeutic option in cardiometabolic risk reduction]. | 2009 | 7 |
| 18 | Alteration of 99mTc-DMSA biodistribution in glomerulonephritis. | 2002 | 5 |
| 19 | 2018 | 4 | |
| 20 | Thyroid blood flow and uptake of technetium-99m pertechnetate in Graves' disease. | 2007 | 4 |
About Slobodan Antić
Slobodan Antić is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (10 papers), Metabolism, Diabetes, and Cancer (8 papers), Diabetes Management and Research (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Pancreatic function and diabetes (3 papers) and Advanced Glycation End Products research (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (859 citations), Pharmacology (201 citations), Periodontics (46 citations), Nephrology (59 citations) and Molecular Biology (464 citations). Slobodan Antić has collaborated with scholars based in Serbia, United Kingdom and Indonesia. Frequent co-authors include Bipin Sethi, David Russell‐Jones, Rafael Simó, O. Schmitz, Nebojša Lalić, Allan Vaag, Marija Zdravković, Vladisav Stefanović, Predrag Vlahović and Gordana Lazarević. Their work appears in journals such as Diabetes & Metabolism, Renal Failure, Annals of Clinical Biochemistry International Journal of Laboratory Medicine, Diabetes Technology & Therapeutics and Clinical Chemistry and Laboratory Medicine (CCLM).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.